Showing 1281-1290 of 1457 results for "".
Empathy and Transactional Medicine: Improving Patient and Physician Outcomes
https://practicaldermatology.com/topics/skin-cancer-photoprotection/transactional-medicine-improving-patient-and-physician-outcomes/20316/For each individual patient, the patient-physician interaction is unique and requires vulnerability, exposure, and discomfort.In Focus: Psoriasis
https://practicaldermatology.com/topics/practice-management/in-focus-psoriasis/21311/AI and Skin of Color: Hidden Biases Raise Questions
https://practicaldermatology.com/topics/skin-of-color/ai-and-skin-of-color-hidden-biases-raise-questions/23994/AI holds potential for practitioners, but it’s important to think critically about what data we use to build models.Etiology, Autoinoculation, and Transmission: What Wart Patients Need to Know
https://practicaldermatology.com/topics/infections-infectious-disease/etiology-autoinoculation-and-transmission-what-wart-patients-need-to-know/23613/Taking time to educate patients can decrease their embarrassment and can lead them to share useful information.Optimizing Wound Healing for Cosmetic and Medical Dermatologic Procedures
https://practicaldermatology.com/topics/practice-management/optimizing-wound-healing-for-cosmetic-and-medical-dermatologic-procedures/20522/Among the options for wound management is hypochlorous acid, a broad-action antimicrobial and anti-inflammatory agent.Rebooting the C. acnes Narrative
https://practicaldermatology.com/topics/acne-rosacea/rebooting-the-ic-acnesi-narrative/23623/Kaposi Sarcoma in HIV-negative Men: A Case Series
https://practicaldermatology.com/youngmd-connect/resident-resource-center/kaposi-sarcoma-in-hiv-negative-men-a-case-series/23158/What Does Efficacy Cost? Evidence for Relative Cost-Effectiveness of Biologic Therapies for Psoriasis
https://practicaldermatology.com/topics/psoriasis/what-does-efficacy-cost-evidence-for-relative-cost-effectiveness-of-biologic-therapies-for-psoriasis/23128/Despite high costs, evidence suggests that biologics are cost-effective options for moderate to severe psoriasis because of their efficacy.New Rosacea Classification System Encourages
More Precise Assessment and Treatmenthttps://practicaldermatology.com/topics/practice-management/new-rosacea-classification-system-encourages-br-more-precise-assessment-and-treatment/20484/A look at the rationale behind the new classification system and what it means for clinicians.The Millennials are Coming
https://practicaldermatology.com/topics/practice-management/the-millennials-are-coming/21131/The new generation learns, interacts, and is inspired differently than a generation ago, and to stay relevant it is necessary to adapt.